Drug intelligence / Profile preview

U-Dream Lite

Development stage
Discontinued
Lead developer
Biotrade Canada
Modality
Small Molecules
Administration
Oral
01

Overview

U-Dream Lite is an orally administered sleep-aid product marketed by Biotrade Canada as a natural herbal supplement for insomnia, particularly to help users return to sleep after waking during the night. Although marketed as containing ingredients such as L-tryptophan, turmeric extract, and tuber fleece flower, regulatory testing found that the product was adulterated with zopiclone impurity 22, an undeclared small molecule structurally related to zopiclone and eszopiclone that likely exerts sedative-hypnotic central nervous system effects through the gamma-aminobutyric acid type A receptor benzodiazepine site in a manner analogous to cyclopyrrolone hypnotics. The product was recalled in the United States and Canada in 2019 because of serious safety risks including excessive sedation, neuropsychiatric effects, dependence, and withdrawal, and its Canadian licenses were suspended.

Brand names
U-Dream Lite
02

Targets

GABAA (Gamma-aminobutyric acid receptor)

Beyond the preview

Go deeper on U-Dream Lite.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on U-Dream Lite.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call